Thrombectomy Device
By designing a thrombectomy device with an expanded and compressed state, thrombectomy fragments are captured using a narrowed area covered by the membrane and ensuring their entry into the catheter through a suction catheter, the problem of incomplete thrombectomy and detachment in the prior art is solved, and the problem of incomplete thrombectomy and detachment in the detachment of the fragments is improved, The integrity and safety of thrombectomy.
Patent Information
- Application Number
- CN201980031735.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2018-03-12
- Filing Date
- 2019-03-06
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2039-03-06
AI Technical Summary
Existing thrombectomy devices are difficult to completely remove after capturing the thrombus, and the thrombus fragments may redisconnect from the device, causing reblocking other blood vessel areas and increasing the risk of stroke.
A device is designed with an expanded and compressed state, released and recovered in the blood vessels through a microcatheter, trapping thrombotic debris using a narrowed constricted area covered by a membrane, and ensuring it into the catheter through a suction catheter to prevent redisengagement.
Effectively capture and remove thrombosis, reduce the risk of thrombosis debris entering other vascular areas, and improve the integrity and safety of thrombectomy.
Smart Images

Figure CN112118795B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a device for removing a thrombus from a blood vessel, wherein the device is arranged in an expanded state and a compressed state, in which the device is released in the blood vessel, and in which the device is introduced into the blood vessel and removed from the blood vessel through a microcatheter, wherein the device has a proximal part, a middle part and a distal part, the middle part has a basically cylindrical structure, and the proximal part is connected to an insertion aid. Background Art
[0002] Thromboembolic diseases, such as myocardial infarction, pulmonary embolism, peripheral thrombosis, organ embolism, etc., are usually caused by thromboembolism (hereinafter referred to as thrombus or clot), i.e., viscoelastic blood clots composed of platelets, fibrinogen, coagulation factors, etc., which are retained in blood vessels and completely or partially occlude the blood vessels. The obstruction of organ arteries can also lead to interruption of oxygen and nutrient supply to related tissues. Immediately after the functional metabolic disorder related to loss of function is structural metabolic failure, resulting in destruction of related tissues (infarction). The organs most frequently affected by this are the heart and brain. However, such changes can also affect the arteries of the limbs and the pulmonary arteries. In addition, venous thrombosis and thromboembolic occlusion often occur in the leg and pelvic veins. The disease mode of thrombotic occlusion of the intracranial sinus may cause severe cerebral hemorrhage due to impaired venous drainage of brain tissue.
[0003] Given the severity of disease patterns associated with thromboembolism and the prevalence of such diseases, various techniques have been developed that aim to dissolve or remove thrombi.
[0004] In this case, it is known to treat such patients with thrombolytic agents such as streptokinase or urokinase or anticoagulants that act to dissolve or inhibit clot growth. Because these treatments are often time consuming, they are often combined with methods for reducing the size of or removing the thrombus or embolus.
[0005] In addition to open surgery, the prior art increasingly involves interventional treatment methods using intraluminal or intravascular catheters, as these methods are less invasive. Thus, it is known to remove clots from a patient's body by means of a suction catheter that generates a vacuum or mechanically using a catheter provided with a capture cage, coil, hook or similar element; see US6245089B1; US5171233A1; Thomas E. Mayer et al., Stroke 2002(9), 2232.
[0006] A disadvantage associated with thrombolytic therapy methods is that they are rarely successful after the associated time limit requirements have expired. In addition, known endoluminal devices often fail to completely remove the clot and there is a risk that the clot or its fragments will be released into the bloodstream and thereby enter smaller lumen vessels where they are difficult to reach or treat.
[0007] A known thrombectomy device is disclosed in WO2012 / 156069A1, which comprises a slit extending in a spiral shape on the outer surface of the device, with a clamping stent at the proximal end, which covers the slit in a wavy manner. After the thrombus is captured, the device is withdrawn into a microcatheter (suction catheter) and removed from the vascular system together with the thrombus. The thrombectomy device is particularly suitable for removing thrombi from small lumens or highly tortuous blood vessels, such as blood vessels of the brain.
[0008] Basically, the thrombectomy devices known from the prior art have proven themselves, but problems can still occur, in that, due to the continuous blood flow, the thrombus can break away from the device again after being captured by the device. In particular in the case of less solid thrombi, there is a risk that parts of the thrombus will be released. Parts of the thrombus released in this way can reach other areas of the vascular system, where they can cause (ischemic) strokes. Summary of the invention
[0009] It is therefore an object of the present invention to provide a device for removing thrombi by which thrombi can be captured and removed from the vascular system, while also preventing the thrombi or thrombus fragments from detaching from the device.
[0010] According to the present invention, this object is achieved by providing a device for removing a thrombus from a blood vessel, wherein the device is arranged in an expanded state and a compressed state, in which the device is released in the blood vessel in the expanded state, and in which the device is introduced into and removed from the blood vessel through a microcatheter in the compressed state, wherein the device has a proximal part, a middle part and a distal part, wherein the middle part has a basically cylindrical structure and the proximal part is connected to an insertion aid, wherein the distal part has a basically cylindrical basic structure and has a narrowing portion between the middle part and the distal part, and the distal part is at least partially covered by a membrane.
[0011] Thrombectomy devices are known from the prior art that are provided with a polymer skin in the distal region that is intended to capture thrombus fragments; however, in these devices, the membrane is stretched and positioned so that the thrombus fragments are captured by the polymer skin inside the device. Since the polymer skin is practically impermeable to blood, problems are encountered when the device is retracted into the microcatheter to finally eliminate the thrombus. The present invention is based on the fact that any thrombus fragments that may occur are intercepted outside the actual device, i.e. in the constriction area, whereby the membrane stretched and positioned in the distal part ensures, by its outer surface, that the thrombus fragments are prevented from entering the more distal regions of the vascular system. When the device is pulled back into the microcatheter, the thrombus fragments captured in the constriction area are thus retracted along the inner wall of the vessel until they are finally pulled back and contained in the microcatheter when the device is withdrawn. It should be noted in this regard that the microcatheter that contains the device and the thrombus is usually a so-called suction catheter, which simultaneously exerts a certain suction effect, thereby also ensuring that the thrombus and the captured thrombus fragments enter the suction catheter.
[0012] In this embodiment, the membrane has essentially a funnel shape, with the thin end of the funnel pointing towards the constriction and the wide end pointing in the distal direction. The membrane is in contact with the inner wall of the vessel over its circumference and is able to collect thrombotic fragments or abrasion. In the context of the present invention, the term "constriction" is to be understood as meaning that the diameter of the device in the constriction area is significantly smaller than the diameter of the middle part and the diameter of the distal part. Preferably, the diameter in the constriction area amounts to ≤80%, preferably ≤70%, more preferably ≤60%, in particular to about 50% of the diameter of the distal part and the middle part.
[0013] With the aid of a microcatheter, the device is navigated to a location in the vascular system for the removal of a thrombus. Here, the device is released again in the area of the thrombus to seal it off. Usually, the release / release takes place in the thrombus itself or distal to the thrombus. This release is achieved by an insertion aid to advance the device in the distal direction or to retract the microcatheter in the proximal direction, while the device is fixed by the insertion aid. By release, it is understood that the device is moved out of the microcatheter so that it can be expanded. Since the device is not designed to remain permanently in the vessel, the device usually remains connected to the insertion aid. The insertion aid is usually an insertion wire. When released, the device assumes an expanded state in which it adapts to the vessel lumen and comes into contact with the inner wall of the vessel. Usually, the expanded state forms a secondary structure that is pre-imprinted on the device. In particular, this applies when the device is made completely or partially of a shape memory material, in particular a shape memory metal. The imprinting of the secondary structure is usually achieved by heat treatment.
[0014] When the device expansion occurs and / or during the retraction process, the thrombus is captured by the device. Once the thrombus is located inside the device or the device has partially penetrated the thrombus, the device is retracted in the direction of the micro (suction) catheter. Retraction can be achieved by moving the insertion auxiliary in the proximal direction. Since the insertion auxiliary is connected to the proximal part of the device, the proximal part of the device also moves toward the catheter, and finally the device and the thrombus are completely contained in the catheter. The clot fragments that are still adhered to the vessel wall are removed and taken away by the shearing action of the strut. Therefore, the thrombus is sucked into the catheter and removed from the body together with the catheter.
[0015] As already mentioned above, a certain amount of suction is usually applied in the direction of the catheter, thereby also ensuring that any clot fragments that may have become dislodged are also sucked in.
[0016] The terms "proximal" and "distal" are to be understood such that they refer to the proximal side of the site pointing toward the attending physician when the device is inserted, and the distal side of the site away from the attending physician. Typically, the device is thus moved forward in the distal direction by means of the microcatheter. The term "axial" refers to the longitudinal axis of the device extending from the proximal side to the distal side, while the term "radial" refers to the horizontal / plane perpendicular to its extension.
[0017] Preferably, at least the middle portion of the device has a large number of openings distributed on its outer surface. In other words, a grid or mesh structure consisting of struts or stents is formed so that the substantially cylindrical structure has a large number of openings or meshes on the outer surface. The size of the openings is dimensioned so that: on the one hand, a captured thrombus cannot pass through the openings and is firmly retained by the device, and on the other hand, blood flow is ensured. In addition, the mesh structure is constructed so that the struts penetrate or even completely cut through the thrombus when released to fix it in place.
[0018] In addition to the middle part, the proximal and / or distal parts may also have a similar structure, which includes openings distributed on the outer surface. In this respect, the structure or design of the proximal part, the middle part and the distal part may not differ significantly, except that the distal part is separated from the middle part by a constriction and is at least partially covered by a membrane, while the proximal part is generally tapered to reduce its diameter in the direction of the insertion aid / insertion line.
[0019] The term "opening" refers to the grid structure, regardless of whether the openings are isolated from the environment by a membrane, which means that even openings covered by a membrane are referred to as openings. Membrane covering is to be understood as any covering of the structure, regardless of whether the membrane is applied to the outside or inside of the grid structure, or whether the grid structure is embedded in a membrane.
[0020] The grid structure of the device or at least the middle part can be a braided structure, that is, it can be composed of individual wires or wire bundles forming struts, which are braided together and extend up and down each other at the intersection of the wires / wire bundles. However, a cut structure is preferred, in which the grid structure is cut out of a tube of appropriate diameter by laser. The material is usually metal, but plastic materials can also be used. The material must have sufficient elasticity to allow contraction to the diameter of a conventional catheter, and in addition, when released from the catheter, expansion to the desired diameter. In addition, advantageously, the grid structure is electropolished to make it smoother and more rounded, thereby reducing trauma. This also reduces the risk of bacteria or other impurities adhering to the structure. The struts or wires can have a circular, oval, square, rectangular or trapezoidal cross-section, wherein, in the case of a square, rectangular or trapezoidal cross-section, the edges are advantageously rounded. A flat net / wire in the form of a thin strip, especially a metal strip, can also be used. In the case of providing rectangular and trapezoidal embodiments, preferably, the narrow side of the cross-section faces the vessel wall, which is conducive to the penetration of thrombi into the grid structure.
[0021] In addition to iron alloys (stainless steel, spring steel) and cobalt-chromium alloys, shape memory alloys such as binary nickel-titanium alloys (Nitinol) and ternary nickel-titanium-chromium alloys (chromium-doped alloys) are particularly suitable for use. Nitinol is known for its use in self-expanding structures in the neurovascular field.
[0022] The device proposed by the present invention can first be manufactured as a flat structure and then rolled into a cylindrical structure. The device can be provided with a slit extending in the longitudinal direction of the device on the outer surface of at least a part of the device. For example, the slit can extend parallel to the longitudinal axis of the device, or extend in a spiral or coiled configuration on the outer surface. In the latter case, the slit can extend in a complete circle / spiral of 360°, but can also be arranged to form only a partial circle / spiral of, for example, 180° or 120°. The spiral configuration of the slit provides additional advantages, wherein, when pulled, the device moves tangentially along the circumference of the vessel wall along the edge of the slit, which improves the shearing effect. In addition, the spiral or coiled extension of the slit also improves (reduces) the bending stiffness, thereby better adapting to the tortuous vessel pattern. This is not only conducive to the placement of the device, but also facilitates the extraction of clots from complex vascular structures. The outer surface of the device is open in the area of the slit, and at the application site, the width of the slit is also determined by the lumen of the vessel, because the device can only be expanded within the range allowed by the lumen of the vessel when it is released from the catheter.
[0023] The slit may extend over the entire length of the device, but preferably, the slit extends over only a portion of the length of the device. In the proximal portion of the device, for example, a clip may be arranged to extend over the slit, as described in WO 2012 / 156069 A1. The clip increases the radial force of the self-expanding structure and also serves to secure the oppositely arranged edges of the device in place relative to each other along the sides of the slit.
[0024] The number of openings arranged adjacent to each other on the outer surface orthogonal to the longitudinal axis of the device is at least 2, but preferably 3 to 5. Adjacent openings are openings that are adjacent to each other orthogonal to the longitudinal axis of the device when the structure is cut and flattened. The correct choice of openings also depends on the size of the blood vessel in which the device is to be used. Generally, the larger the diameter of the blood vessel, the more adjacent openings are arranged side by side, because in the expanded state, the device must cover a larger total circumferential area. In addition, generally, a smaller number of openings makes the device more flexible, which is advantageous when the device must navigate in a sharp bend in a blood vessel. On the other hand, with the same outer surface area, a smaller number of openings also means an increase in the size of the opening. The size of the opening should be selected to prevent thrombi or thrombus fragments from escaping through the opening to the extent possible. Generally, it has been proven that the use of the following device is a good practice method: wherein the number of openings arranged adjacent to each other along the circumference on the outer surface orthogonal to the longitudinal axis of the device is 3 to 5.
[0025] It has been found useful that the membrane arranged in the distal part of the device has at least one opening, which is preferably centrally located. When the membrane has a funnel shape as a whole, the opening is therefore located at the thin end in the middle of the funnel. The opening ensures that blood flows through the device even when a substantially liquid-tight membrane is used, thereby reducing the risk of ischemia. In addition, since the opening prevents congestion, it also facilitates the retraction of the device towards the catheter.
[0026] The constriction arranged between the middle portion and the distal portion is preferably produced by heat treatment. In other words, the device is initially manufactured in its normal cylindrical configuration and subsequently heat treated to form the constriction, which constitutes an essential feature of the described embodiments of the invention. For this purpose, the device is exposed to heat to create a condition in which the device can be deformed particularly well to form the constriction, in particular when using a shape memory material such as Nitinol.
[0027] According to an alternative embodiment considered independently of the embodiments set forth above, the present invention relates to a device for removing a thrombus from a blood vessel, the device being arranged in an expanded state and a compressed state, in which the device is released in the blood vessel, and in which the device is introduced into and removed from the blood vessel via a microcatheter, the device having a proximal portion, a middle portion and a distal portion, wherein at least the middle portion and the distal portion have a structure of essentially cylindrical struts, thereby forming a plurality of openings distributed on the outer surface of the device, and the proximal portion is connected to an insertion aid, wherein the struts are bent inwardly at the distal end of the distal portion, and the distal portion is at least partially covered by a membrane.
[0028] According to this alternative embodiment, thrombi that are detached from the device or thrombus fragments that are detached from the thrombus are collected by the distal end of the device covered by the membrane. In this regard, it is most important that the struts at the distal end of the distal portion are bent inwardly and the distal end is circular as a whole. In this way, the distal end forms a convex shape including an aperture or a grid. Therefore, the distal end becomes significantly more atraumatic, thereby reducing the risk of damaging the vessel wall. In addition, the struts are bent inwardly at the distal end so that the membrane is firmly held in place and will not be overstretched at any time, because this will increase the risk of membrane rupture. Because the struts are bent inwardly, that is, bent in the direction of the longitudinal axis of the device extending in the center of the device, the distal end of the device has an overall circular shape and can therefore be easily navigated in the blood vessel.
[0029] Since the membrane in the second embodiment of the invention generally has no openings, the membrane should be at least partially permeable to liquid, in this case especially blood. In this way, it is ensured that the overall flow of blood through the blood vessel is maintained. In addition, when blood is allowed to pass through the membrane from one side of the membrane to the other side, i.e. the distal side, it is facilitated to retract the device into the catheter.
[0030] The permeability of the membrane can be adjusted as desired to achieve a more or less effective filtration effect. On the one hand, a high permeability will be beneficial for blood flow, while on the other hand, a low permeability is advantageous to ensure that even small thrombus fragments are intercepted.
[0031] Similar to the first embodiment, it is also useful for the second embodiment that the number of openings located adjacent to each other on the outer surface orthogonal to the longitudinal axis of the device is at least 2, preferably 3 to 5. Regarding the selection criteria for controlling the optimal number of openings, the above description for the first embodiment also applies.
[0032] In general, statements made in connection with the first embodiment of the invention apply in the same manner to the second embodiment, unless the design or context of the device indicates or requires otherwise. In particular, statements regarding the grid / mesh structure, the construction including individual openings, the materials used or the provision of slits in the device, and the operation of the device also apply to the second embodiment.
[0033] The bending of the struts at the distal end of the distal portion is preferably achieved by heat treatment. In other words, the device is initially manufactured in its normal cylindrical structure and then heat treated to have a specific effect on the configuration of the struts at the distal end. For this purpose, the device is exposed to heat to create a condition in which the device can be deformed particularly well to achieve rounding of the distal end, especially when using a shape memory material such as Nitinol.
[0034] The following applies to both embodiments of the invention: The insertion aid is preferably an insertion wire, as it is sufficiently well known in the prior art. The insertion aid can be connected to the proximal part of the device at one or more attachment points. Typically, the struts of the device converge in the proximal part towards the insertion aid. Advantageously, one or more connection points are arranged offset in the direction of the outer surface relative to the longitudinal axis extending centrally of the device, i.e., positioned radially outwards. This eccentric arrangement of the connection or attachment points provides the advantage that the blood flow is disturbed as little as possible. When the device is released from the microcatheter, the connection point can therefore be positioned so as to be in contact with the vessel wall.
[0035] Significantly, the device is provided with one or more radiopaque markers, thereby allowing the attending physician to see it. The radiopaque markers may, for example, be composed of platinum, palladium, platinum-iridium, tantalum, gold, tungsten or other radiopaque metals. They allow the attending physician to see whether the device is correctly positioned relative to the thrombus to be removed and to make corrections if necessary. It is also conceivable that at least some areas of the device are provided with a coating of radiopaque material, such as a gold coating. The thickness of the coating may, for example, be between 1 and 6 μm. The coating with radiopaque material does not need to be applied to the entire device. However, even if a radiopaque coating is provided, it may also be useful to arrange one or more additional radiopaque markers. Another possibility is to wrap each strut with a spiral or linear portion composed of a radiopaque material, such as platinum.
[0036] Particularly for the second embodiment of the invention, it can be seen that it is advantageous to provide a radiopaque marker in the region of the proximal end of the membrane coverage, that is, where the membrane coverage begins when viewed from the proximal end. When the device is retracted into the aspiration catheter, the attending physician is able to determine from the position of the radiopaque marker when the covered proximal end reaches the distal entrance of the aspiration catheter. It is recommended not to withdraw the device further into the aspiration catheter to avoid "squeezing out" of captured thrombus fragments, but to move the aspiration catheter without the device being fully retracted proximally and then remove it from the vascular system. .
[0037] In the case where the device is covered by a membrane, it may be attached to the grid structure internally or externally. Preferably, however, the lattice structure is embedded in the membrane. This can be achieved by first providing a grid structure and subsequently spinning or weaving fibers around the grid structure to form a membrane with an embedded grid structure. Related processes are well known in the prior art, such as the so-called electrospinning method.
[0038] It is also possible to initially provide a mandrel on which a first film is applied. Subsequently, the grid structure itself is applied to the first film and then finally to the second film. In this way, the individual struts constituting the device are surrounded by the film. In areas of the device where a film does not necessarily have to be arranged or is not needed, the film can still be removed later.
[0039] As far as a membrane is mentioned within the scope of the present invention, it should be clearly understood that this can also mean more than one membrane. Thus, there may be a continuous membrane covering a larger area of the device, but it is also conceivable to provide a plurality of individual membranes to cover certain areas of the device. These individual membranes can be positioned next to each other to form a uniform surface, but there can also be gaps between the membranes, as long as the purpose associated with the device is to capture thrombus fragments. The membrane can consist of multiple layers. In the case of an arrangement of a plurality of membranes or membrane layers on top of each other, this arrangement should also be understood as a membrane in the sense of the present invention.
[0040] In the electrostatic spinning process preferably adopted, fibrils or fibers are separated from the polymer solution and deposited on a substrate by applying an electric current. The deposition causes the fibrils to condense into a nonwoven fabric. Typically, the diameter of the fibrils is in the range of 100 to 3000 nm. The film obtained by electrostatic spinning has a very uniform structure. The film is tough, can withstand mechanical stress, and can be mechanically pierced without producing an opening so as to produce cracks therefrom. The thickness and porosity of the fibrils can be controlled by appropriately selecting process parameters. In the case of manufacturing a film and about materials suitable for this purpose, special attention should be paid to publications WO 2008 / 049386 A1, DE 2806030 A1 and the literature cited therein.
[0041] In addition to using electrospinning, membranes can also be produced by immersion or spray processes (eg, "spraying").
[0042] The film can be made of a polymer material such as polytetrafluoroethylene, polyester, polyamide, polyurethane or polyolefin. Particularly preferred is polycarbonate polyurethane (PCU), which can be applied, for example, in a solvent such as chloroform. The integral connection of the film with the grid structure is particularly desirable. By silanizing the struts, the adhesion of the film to the struts forming the grid structure can be further improved.
[0043] The connection point can be a simple welding point where the auxiliary insertion device / insertion line and the proximal part of the device are put together. Conventional connecting elements can also be considered, through which the device can be detached. Although it is usually not intended that the device proposed by the present invention be retained in the placement position, unlike, for example, a stent, this is necessary in special cases when withdrawal is not indicated for medical reasons, for example, because this will cause harm to the patient. In this case, the device can be retained in the body like a stent and can be effectively used because it will form a channel or channel in the clot, so the grid structure will cause the clot to be pressed on the vessel wall, and blood flow is maintained due to the permeability of the membrane (with or without openings). The membrane can be made of, for example, polycarbonate polyurethane, which dissolves in the body over time and therefore will not have a further impact on blood flow.
[0044] Removable coupling elements for occlusive coils or stents are widely described in the literature, in particular those based on electrolytic, thermal or mechanical separation techniques. Particularly suitable are electrolytic separation systems, in which the electrolytically corrodible parts are dissolved by applying electrical energy, resulting in the connection between the device and the insertion aid being severed. Suitable separation elements are pre-corroded stainless steel elements, magnesium elements or cobalt-chromium alloys. Mechanical separation techniques generally involve a form closure that disengages when the device is separated, causing the device to be disconnected from the insertion aid.
[0045] The insertion wire may be of one-piece design, in which case the insertion wire is substantially of continuous form. However, the advantageous properties of different materials may also be combined, for example, the more proximally positioned portion of the insertion wire may be made of stainless steel, thereby facilitating forward movement, while the more distal portion of the insertion wire may be made of a nickel-titanium alloy such as Nitinol, thereby providing a higher flexibility. The distal portion consisting of a nickel-titanium alloy also has the advantage of minimizing the risk of kinking ("kink resistance"). On the other hand, for the proximal portion of the insertion wire, it is advantageous to use a harder material such as stainless steel, since it is able to transmit torque, which is advantageous since it improves forward movement.
[0046] The term "insertion aid" should be understood in a broad sense and does not necessarily always refer to an insertion cord in the conventional sense of the word. For example, other elongated insertion aids with a hollow interior space may also be used.
[0047] Typically, the device of the invention has a length (without insertion aid) in the range of 5 mm to 40 mm and a diameter of 1.5 mm to 7 mm, the dimensions being determined by the size of the vessel from which the thrombus is to be removed. The figure shows the device in a free relaxed state, i.e., without any external force applied by the catheter. The struts forming the device may, for example, have a width, a diameter in the range of 20 to 60 μm.
[0048] In addition to the device itself, the invention also relates to a method for manufacturing the device, which is characterized in that a constriction is formed between the middle portion and the distal portion by heat treatment, and the struts are rounded at the distal end of the distal portion.
[0049] Furthermore, the present invention also relates to the use of the device according to the invention for removing a thrombus from a blood vessel.
[0050] The present invention will now be described in detail by way of example below with reference to the accompanying drawings showing various embodiments. It should be noted that the accompanying drawings show preferred embodiment variants of the present invention, but the present invention should not be considered to be limited to these variants. Within the technically advantageous range, the present invention generally includes any optional combination of the technical features related to the present invention described in the claims or the specification. BRIEF DESCRIPTION OF THE DRAWINGS
[0051] The invention is described by means of the following drawings, in which:
[0052] Figure 1 shows a device according to a first variant of the first embodiment in an expanded form, without a membrane;
[0053] Figure 2a is a side view of a device according to a first variation of the first embodiment, shown without a membrane;
[0054] Figure 2b is a front view of a device according to a first variation of the first embodiment, shown without a membrane;
[0055] Figure 3a is a side view of a device according to a first variation of the first embodiment, shown without a membrane;
[0056] Figure 3b is a front view of a device according to a first variation of the first embodiment, shown without a membrane;
[0057] Figure 4 shows a device according to a second variant of the first embodiment in an expanded form, without a membrane;
[0058] Figure 5a is a side view of a device according to a second variation of the first embodiment, shown without the membrane;
[0059] Figure 5b is a front view of a device according to a second variation of the first embodiment, shown without the membrane;
[0060] Figure 6a is a side view of a device according to a second variation of the first embodiment, shown with a membrane;
[0061] Figure 6b is a front view of a device according to a second variation of the first embodiment, shown with a membrane;
[0062] Figure 7 The device according to the second embodiment is shown in an unfolded form, without the membrane;
[0063] Figure 8 is a side view of a device according to a second embodiment prior to distal end rounding, shown without a membrane;
[0064] Fig. 9 is a side view of a device according to a second embodiment after distal end rounding, shown without a membrane;
[0065] Fig.10a is a side view of a device according to a second embodiment prior to distal rounding, shown with a membrane;
[0066] Fig.10b is a front view of a device according to a second embodiment after distal end rounding, shown with a membrane;
[0067] Fig.11a As Fig.10a A side view of a device according to the second embodiment after distal rounding of a variation of , shown with a membrane; and
[0068] Fig.11b As Fig.10b A front view of a device according to a second embodiment after distal rounding of a variation of the device shown with a membrane. DETAILED DESCRIPTION
[0069] exist Figure 1 In the figure, the device 1 proposed by the invention is shown according to a first variant of the first embodiment, wherein the device 1 is shown in an expanded form and without a membrane. In fact, it can be clearly seen from the figure that the device 1 is essentially cylindrical. The device 1 is provided with a portion 2 of gradually tapering and converging cross-section located on the proximal side, as well as an intermediate cylindrical portion 3 and a distal portion 4. It consists of individual struts 8, which form openings 9. In this case, the number of openings 9 arranged adjacent to each other orthogonal to the longitudinal axis of the device 1 is three. The dot-dash line indicates the connection with the struts 8 on the opposite side of the device 1.
[0070] Between the middle portion 3 and the distal portion 4 there is a region in which the device 1 exhibits fewer struts 8, said region being arranged so that a constriction can be formed during the process of converting the device 1 into a cylindrical shape.
[0071] Figure 2a Shown in side view Figure 1 , but the device is not yet provided with a membrane. Furthermore, the illustration of the single opening 9 is omitted. Likewise, the proximal part 2, the middle part 3 and the distal part 4 can be seen, wherein the constriction 6 is located between the middle part 3 and the distal part 4, said constriction being produced by heat treatment of the struts 8. At the proximal end, the device 1 ends in a connection point 11, via which the device 1 is attached to the insertion aid 5.
[0072] exist Figure 2b In the figure, a front view is shown. Figure 1 and 2a The device 1 shown in FIG. 1 , but again without the membrane forming an intrinsic part of the present invention. It can be seen that on the outer surface of the device 1 three openings 9 are arranged adjacent to each other.
[0073] Figure 3a Corresponds to Figure 2a but after the device 1 has been provided with the membrane 7. Figure 3b As can be seen from the front view of the membrane 7, the membrane 7 has an opening 10 in the center. It is used to permanently maintain the blood flow.
[0074] exist Figure 4 , select something like Figure 1 to provide a variation of the device 1. Basically, Figure 4 Similar to Figure 1 , but in this case, the number of openings 9 arranged adjacent to each other is four, wherein these holes 9 are naturally positioned radially side by side on the outer surface of the device 1 and form a cylindrical structure as a whole.
[0075] Figure 5a The side view shows the Figure 4 A variation of , in which the membrane has not yet been arranged. Figure 2a Instead, struts 8 are shown which form openings 9. Furthermore, a constriction 6 between the middle section 3 and the distal section 4 can be seen.
[0076] Figure 5b Shown in front view Figure 5a The device shown in , again without a membrane. It should be noted that the number of openings 9 arranged adjacent to each other on the outer surface amounts to four.
[0077] Figure 6a Shows Figure 5abut this time after completion, ie including the membrane 7. Figure 6b As can be seen from the relevant front view of FIG. 1 , the membrane 7 has a central opening 10 .
[0078] exist Figure 7 In FIG. 4 , a second embodiment of the device 1 is shown, which is also without a membrane and without a constriction between the middle part 3 and the distal part 4 . Figure 7 An expanded representation of the device 1 is shown. The dash-dotted line indicates that in practice there is followed by an oppositely positioned opening 9. The proximal portion 2 converges narrowly towards the proximal end.
[0079] Figure 8 Shown according to Figure 7 The development process of the device of the second embodiment, in which the device 1 is already in Figure 8 At the proximal portion 2, the struts 8 forming the opening 9 finally converge at a connection point 11, wherein the device 1 is connected to the insertion aid 5 via this connection point. Figure 8 It can be seen that the distal end in the distal portion 4 has not yet been rounded.
[0080] Fig. 9 , ie here the struts 12 at the distal end of the distal portion 4 are bent inwardly, so that the distal portion 4 has an overall curved or convex shape. The membrane 7 is not arranged here.
[0081] In conclusion, Fig.10a Shown in side view Figures 7 to 9 The complete device 1. This diagram is similar to Fig. 9 The difference shown is that in this case the membrane is arranged in the distal part 4. Fig.10b A corresponding front view can be seen in FIG, which shows the membrane 7 and the inwardly bent struts 12.
[0082] Fig.11a yes Fig.10a The variation of the device 1 shown in FIG. 1 , in which the distal portion 4 covered by the opening 9 of the membrane 7 extends further proximally, on the other hand, in the front view Fig.11b and Fig.10b The variants shown do not differ.
Claims
1. A device for removing a thrombus from a blood vessel, wherein: The device (1) is arranged in an expanded state and a compressed state, in which the device (1) is temporarily released in the blood vessel and in which the device (1) is introduced into and removed from the blood vessel via a microcatheter, wherein the device (1) has a proximal part (2), a middle part (3) and a distal part (4), wherein the middle part (3) has a substantially cylindrical structure and the proximal part (2) is connected to an insertion aid (5), wherein the distal part (4) has a substantially cylindrical basic structure and is at least partially covered by a membrane (7), It is characterized in that A constriction (6) is arranged between the middle section (3) and the distal section (4), wherein the membrane (7) has a funnel shape, wherein the thin end of the funnel points towards the constriction (6) and the wide end of the funnel points in the distal direction.
2. The device according to claim 1, characterized in that At least the middle portion (3) comprises a plurality of openings (9) distributed on its outer surface.
3. The device according to claim 2, characterized in that The number of openings (9) arranged adjacent to each other on the outer surface orthogonal to the longitudinal axis of the device is at least two.
4. The device according to any one of claims 1 to 3, characterized in that The membrane (7) is provided with at least one opening (10).
5. The device according to claim 4, characterized in that The opening (10) is located in the center of the membrane (7).
6. The device according to any one of claims 1 to 3, characterized in that The insertion aid (5) is connected to the proximal part (2) of the device (1) at one or more connection points (11), wherein the connection points (11) are arranged radially offset in the direction of the outer surface relative to a longitudinal axis extending centrally of the device (1).
7. The device according to any one of claims 1 to 3, characterized in that It comprises a slit extending in the longitudinal direction of the device (1) on the outer surface of at least a part of the device (1).
8. The device according to claim 7, characterized in that The slit extends parallel to the longitudinal axis of the device (1).
9. The device according to claim 7, characterized in that The slits extend helically on the outer surface.
10. The device according to any one of claims 1 to 3, characterized in that At least some areas of the device (1) are provided with a radiopaque coating.
11. The device according to claim 7, characterized in that The number of openings (9) arranged adjacent to each other on the outer surface orthogonal to the longitudinal axis of the device is 3 to 5.
12. A method for manufacturing a device (1) according to any one of claims 1 to 11, characterized in that: A constriction (6) is formed between the middle portion (3) and the distal portion (4) by heat treatment, or the struts (8) are rounded at the distal end of the distal portion (4).
